He Lian
- Biomaterials top 2%
- Biomedical Engineering top 5%
- Molecular Biology
- Pharmaceutical Science top 1%
- Biotechnology top 2%
- Topics
- Nanoparticle-Based Drug Delivery (12 papers)Nanoplatforms for cancer theranostics (10 papers)Advanced Drug Delivery Systems (9 papers)
- Journals
- Advanced MaterialsSHILAP Revista de lepidopterologíaChemical Engineering Journal
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
He Lian
77 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 133
- Biomaterials 683
- Biomedical Engineering 660
- Molecular Biology 598
- Pharmaceutical Science 279
- Biotechnology 217
Countries citing papers authored by He Lian
This map shows the geographic impact of He Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Lian more than expected).
Fields of papers citing papers by He Lian
This network shows the impact of papers produced by He Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Lian. The network helps show where He Lian may publish in the future.
Co-authorship network of co-authors of He Lian
This figure shows the co-authorship network connecting the top 25 collaborators of He Lian. A scholar is included among the top collaborators of He Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with He Lian. He Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 32 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 8 | |
| 8 | 85 | |
| 9 | 11 | |
| 10 | 22 | |
| 11 | 17 | |
| 12 | 16 | |
| 13 | 20 | |
| 14 | 43 | |
| 15 | 50 | |
| 16 | 16 | |
| 17 | 73 | |
| 18 | 8 | |
| 19 | 18 | |
| 20 | P2P Overlay Network Clustering Service | 1 |
About He Lian
He Lian is a scholar working on Pharmaceutical Science, Biomaterials and Nephrology, having authored 82 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (10 papers) and Advanced Drug Delivery Systems (9 papers). The work is most often cited by research in Biomaterials (683 citations), Pharmaceutical Science (279 citations) and Biotechnology (217 citations). He Lian has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhaoxu Meng, Jin Sun, Zhonggui He, Yongjun Wang, Yinghua Sun, Yanhua Liu, Wen Cao, Liqiu Xia, Siling Wang and Shengbiao Hu. Their work appears in journals such as Advanced Materials, SHILAP Revista de lepidopterología and Chemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.